Drugs / Ezacard
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04274803 Comparator | Apr 2020 → May 2021 | antiphospholipid syndrome | Tanta University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ezacard | “Dual low dose aspirin (LDA) (Ezacard 75mg) once daily” NCT04274803 ↗ |
| Known as | aspirin | “Dual low dose aspirin (LDA) (Ezacard 75mg) once daily” NCT04274803 ↗ |